🚀 VC round data is live in beta, check it out!

Harvard Apparatus Valuation Multiples

Discover revenue and EBITDA valuation multiples for Harvard Apparatus and similar public comparables like AnteoTech, Proteomics, Bio-Works Technologies, Genoway and more.

Harvard Apparatus Overview

About Harvard Apparatus

Harvard Apparatus Regenerative Technology Inc is a clinical-stage biotechnology company developing regenerative-medicine treatments for disorders of the gastrointestinal system and the airway resulting from cancer, trauma, or birth defects. The company's technology is based on its proprietary cell-therapy platform that uses a patient’s stem cells to regenerate and restore function to damaged organs.


Founded

2012

HQ

United States

Employees

8

Financials (FY)

Revenue: $704K
EBITDA: ($7M)

EV

$26M

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Harvard Apparatus Financials

Harvard Apparatus reported last fiscal year revenue of $704K and negative EBITDA of ($7M).

In the same fiscal year, Harvard Apparatus generated $58K in gross profit, ($7M) in EBITDA losses, and had net loss of ($7M).

Revenue (LTM)


Harvard Apparatus P&L

In the most recent fiscal year, Harvard Apparatus reported revenue of $704K and EBITDA of ($7M).

Harvard Apparatus expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Harvard Apparatus forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
RevenueXXX$704KXXXXXXXXX
Gross ProfitXXX$58KXXXXXXXXX
Gross MarginXXX8%XXXXXXXXX
EBITDAXXX($7M)XXXXXXXXX
EBITDA MarginXXX(960%)XXXXXXXXX
EBIT MarginXXX(982%)XXXXXXXXX
Net ProfitXXX($7M)XXXXXXXXX
Net MarginXXX(976%)XXXXXXXXX

Financial data powered by Morningstar, Inc.

Harvard Apparatus Stock Performance

Harvard Apparatus has current market cap of $28M, and enterprise value of $26M.

Market Cap Evolution


Harvard Apparatus' stock price is $1.57.

See Harvard Apparatus trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$26M$28M0.0%XXXXXXXXX$-0.39

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Harvard Apparatus Valuation Multiples

Harvard Apparatus trades at 37.6x EV/Revenue multiple, and (3.9x) EV/EBITDA.

See valuation multiples for Harvard Apparatus and 15K+ public comps

EV / Revenue (LTM)


Harvard Apparatus Financial Valuation Multiples

As of April 19, 2026, Harvard Apparatus has market cap of $28M and EV of $26M.

Equity research analysts estimate Harvard Apparatus' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Harvard Apparatus has a P/E ratio of (4.0x).

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$28MXXX$28MXXXXXXXXX
EV (current)$26MXXX$26MXXXXXXXXX
EV/RevenueXXX37.6xXXXXXXXXX
EV/EBITDAXXX(3.9x)XXXXXXXXX
EV/EBITXXX(3.8x)XXXXXXXXX
EV/Gross ProfitXXX456.6xXXXXXXXXX
P/EXXX(4.0x)XXXXXXXXX
EV/FCFXXX(6.9x)XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Harvard Apparatus Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Harvard Apparatus Margins & Growth Rates

Harvard Apparatus' revenue in the last fiscal year grew by 64%.

Harvard Apparatus' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.9M for the same period.

See operational valuation multiples for Harvard Apparatus and other 15K+ public comps

Harvard Apparatus Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue GrowthXXX64%XXXXXXXXX
EBITDA MarginXXX(960%)XXXXXXXXX
EBITDA GrowthXXX(10%)XXXXXXXXX
Revenue per EmployeeXXX$0.1MXXXXXXXXX
Opex per EmployeeXXX$0.9MXXXXXXXXX
S&M Expenses to RevenueXXX10%XXXXXXXXX
G&A Expenses to RevenueXXX604%XXXXXXXXX
R&D Expenses to RevenueXXX377%XXXXXXXXX
Opex to RevenueXXX990%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Harvard Apparatus Public Comps

See public comps and valuation multiples for other Life Sciences Tools comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
Harvard ApparatusXXXXXXXXXXXXXXXXXX
AnteoTechXXXXXXXXXXXXXXXXXX
ProteomicsXXXXXXXXXXXXXXXXXX
Bio-Works TechnologiesXXXXXXXXXXXXXXXXXX
GenowayXXXXXXXXXXXXXXXXXX
BiohitXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Harvard Apparatus M&A Activity

Harvard Apparatus acquired XXX companies to date.

Last acquisition by Harvard Apparatus was on XXXXXXXX, XXXXX. Harvard Apparatus acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Harvard Apparatus

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Harvard Apparatus Investment Activity

Harvard Apparatus invested in XXX companies to date.

Harvard Apparatus made its latest investment on XXXXXXXX, XXXXX. Harvard Apparatus invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Harvard Apparatus

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Harvard Apparatus

When was Harvard Apparatus founded?Harvard Apparatus was founded in 2012.
Where is Harvard Apparatus headquartered?Harvard Apparatus is headquartered in United States.
How many employees does Harvard Apparatus have?As of today, Harvard Apparatus has over 8 employees.
Is Harvard Apparatus publicly listed?Yes, Harvard Apparatus is a public company listed on OTC Pink Sheets.
What is the stock symbol of Harvard Apparatus?Harvard Apparatus trades under HRGN ticker.
When did Harvard Apparatus go public?Harvard Apparatus went public in 2013.
Who are competitors of Harvard Apparatus?Harvard Apparatus main competitors are AnteoTech, Proteomics, Bio-Works Technologies, Genoway.
What is the current market cap of Harvard Apparatus?Harvard Apparatus' current market cap is $28M.
What is the current revenue of Harvard Apparatus?Harvard Apparatus' last fiscal year revenue is $704K.
What is the current EV/Revenue multiple of Harvard Apparatus?Current revenue multiple of Harvard Apparatus is 37.6x.
Is Harvard Apparatus profitable?No, Harvard Apparatus is not profitable.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial